HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL’s proforma annualized revenue run-rate to be greater than $65 million and… Read More
Getinge announces the launch of Pulsiocare, an advanced hemodynamic monitoring platform that recently received its CE certificate. The state-of-the-art device is based on the global medtech company’s award-winning common user… Read More
Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 EU Marketing Authorization Application (MAA) submission also validated by European Medicines… Read More
When it comes to managing blood sugar levels, most people think about counting carbs. But new research from the University of British Columbia shows that, for some, it may be… Read More
CARVYKTI® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S. FDA for the treatment of patients with multiple myeloma who have had at least one prior line… Read More
